Beneficios de la terapia nebulizada: conceptos básicosBenefits of nebulized therapy: basic concepts
Bibliografía (12)
- et al.
Diagnóstico y tratamiento de las bronquiectasias
Arch Bronconeumol
(2008) - et al.
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
J Cyst Fibros
(2009) - et al.
European Respiratory Society Guidelines Task Force on the use of nebulizers. European Respiratory Society Guidelines on the use of nebulizers
Eur Respir J
(2001) Nebulizers: principles and performance
Respir Care
(2000)- et al.
Terapias respiratorias
Arch Bronconeumol
(2009) - et al.
Consensus statement: aerosols and delivery devices. American Association for Respiratory Care
Respir Care
(2000)
Cited by (12)
Are Inhalation Devices Important in Antibiotic Treatment?
2020, Archivos de BronconeumologiaBases for the use of nebulizers in primary care
2019, FMC Formacion Medica Continuada en Atencion PrimariaNebulized Therapy. SEPAR Year
2014, Archivos de BronconeumologiaCitation Excerpt :The 3 modalities commonly used are pressurized metered-dose inhalers, dry powder inhalers, and nebulizers. As a general rule, nebulizers are not recommended if the drug can be administered using other devices.1–4 The European Respiratory Society2 recommends them for patients who require high doses of bronchodilators, when they need to inhale drugs that only exist in this form (antibiotics or dornase alfa), or when they are unable to use other inhalation devices.2
Nebulized antibiotic therapy
2014, Archivos de BronconeumologiaTreatment of non-cystic fibrosis bronchiectasis
2011, Archivos de BronconeumologiaCitation Excerpt :The tobramycin solution for nebulizer (TOBI®, Novartis; Bramitob®, Chiesi) and sodium colistimethate (GES®, G.E.S. Genéricos Españoles Laboratorio; Promixin®, Praxis Pharmaceutical) are the two antibiotics available on the market apt for inhaled use in patients with bronchiectasis (formal indication in CF and compassionate indication in bronchiectasis of other origins). It is administered by means of jet nebulizers (Pari LC Plus®) or dynamic or static mesh electronic nebulizers (eFlow rapid® and I-neb®).50 In comparison with the jet nebulizers, the mesh ones are less voluminous, more silent, faster and more portable.
New Inhaled Antibiotics and Forms of Administration
2020, Open Respiratory Archives